Interferon regulatory factor‐8 modulates the development of tumour‐induced CD11b+Gr‐1+ myeloid cells
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Tumour‐induced myeloid‐derived suppressor cells (MDSC) promote immune suppression and mediate tumour progression. However, the molecular basis for the generation of MDSC, which in mice co‐express the CD11b+ and Gr‐1+ cell surface markers remains unclear. Because CD11b+Gr‐1+ cells expand during progressive tumour growth, this suggests that tumour‐induced events alter signalling pathways that affect normal myeloid cell development. Interferon regulatory factor‐8 (IRF‐8), a member of the IFN‐γ regulatory factor family, is essential for normal myelopoiesis. We therefore examined whether IRF‐8 modulated tumour‐induced CD11b+Gr‐1+ cell development or accumulation using both implantable (4T1) and transgenic (MMTV‐PyMT) mouse models of mammary tumour growth. In the 4T1 model, both splenic and bone marrow‐derived CD11b+Gr‐1+ cells of tumour‐bearing mice displayed a marked reduction in IRF‐8 expression compared to control populations. A causal link between IRF‐8 expression and the emergence of tumour‐induced CD11b+Gr‐1+ cells was explored in vivo using a double transgenic (dTg) mouse model designed to express transgenes for both IRF‐8 and mammary carcinoma development. Despite the fact that tumour growth was unaffected, splenomegaly, as well as the frequencies and absolute numbers of CD11b+Gr‐1+ cells were significantly lower in dTg mice when compared with single transgenic tumour‐bearing mice. Overall, these data reveal that IRF‐8 plays an important role in tumour‐induced development and/or accumulation of CD11b+Gr‐1+ cells, and establishes a molecular basis for the potential manipulation of these myeloid populations for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 1×
“These cells have been shown to expand extensively with progressive tumor growth [4, 5, 8, 12, 22].”
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140 · cited 2×
“3940 and peripheral lymphoid organs, they can also infiltrate tumour tissue and constitute approximately 5% of the total cells within the mass [13].”
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847 · cited 1×
“Conversely, these tumour-induced CD11b Gr-1 cells (including mouse 3) secreted significantly higher levels of IL-10, a MDSC-associated cytokine [34, 35], compared with control cells (P 0.”
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · cited 5×
“leads to a marked accumulation of macrophages, neutrophils and CD11bGr-1 cells in the spleen, lymph nodes, peripheral blood and bone marrow [17-19].”
InfluentialHyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464 · cited 1×
“Stat3 activation in the development of these cells [1, 38], follow-up investigations are needed to reveal the precise molecular or biochemical relationship between these two transcription factors, IRF-8 and Stat3.”
Tumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer
Lin, E. Y., & Pollard, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0912 · Cited by 463 · cited 1×
“This model has also been used to study the role of tumor-associated macrophages in tumor progression [29].”
Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · cited 4×
“leads to a marked accumulation of macrophages, neutrophils and CD11bGr-1 cells in the spleen, lymph nodes, peripheral blood and bone marrow [17-19].”
Influential
Cited by
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Marvel, D., & Gabrilovich, D. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80005 · Cited by 1,050
Ostrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509
“As a result, IRF8-deficient mice have high levels of PMN-MDSC (103, 104), and overexpression of IRF8 in the myeloid lineage reduces MDSC accumulation (105, 106).”
BackgroundMyeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Wu, Y., Yi, M., Niu, M., Mei, Q., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01657-y · Cited by 458
Transcriptional regulation of myeloid-derived suppressor cells
Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ri0515-204r · Cited by 372
Mastio, J., Condamine, T., Dominguez, G., Kossenkov, A. V., Donthireddy, L., Veglia, F., Lin, C., Wang, F., Fu, S., Zhou, J., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181952 · Cited by 115
“Its down-regulation was previously implicated in the accumulation of PMN-MDSCs (Stewart et al., 2009; Waight et al., 2013; Paschall et al., 2015).”
Self-citation
Metadata
- Authors
- Stewart, T. J., Greeneltch, K. M., Reid, J. E., Liewehr, D. J., Steinberg, S. M., Liu, K., & Abrams, S. I.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 13
- Issue
- 9b
- Pages
- 3939-3950
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2110690959
- Cited by
- 52
- References
- 12
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon regulatory factor‐8 modulates the development of tumour‐induced CD11b+Gr‐1+ myeloid cells. https://app.cochat.ai/papers/10.1111/j.1582-4934.2009.00685.x
- The paper
- Stewart, T. J., Greeneltch, K. M., Reid, J. E., Liewehr, D. J., Steinberg, S. M., Liu, K., & Abrams, S. I. (2009). Interferon regulatory factor‐8 modulates the development of tumour‐induced CD11b+Gr‐1+ myeloid cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2009.00685.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.